The Role of Acute Combined PPAR Alpha and Gamma Stimulation on Insulin Action in Humans

PHASE4CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

December 31, 2000

Primary Completion Date

July 31, 2011

Study Completion Date

July 31, 2011

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

Pioglitazone

This was a randomized placebo-controlled crossover study in which subjects received both agents in random order, separated by a wash-out period. Following 10 or 21 days' intervention, subjects underwent a pancreatic clamp study.

DRUG

Placebo

This was a randomized placebo-controlled crossover study in which subjects received both agents in random order, separated by a wash-out period. Following 10 or 21 days' intervention, subjects underwent a pancreatic clamp study.

PROCEDURE

Pancreatic Clamp Study

During the clamp procedure, glucose (a sugar) and insulin were infused with an IV catheter, and blood samples were collected periodically throughout the procedure to measure blood sugar levels and the levels of several hormones that are found in the body and are related to glucose metabolism.

Trial Locations (1)

10461

Albert Einstein College of Medicine, The Bronx

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Takeda

INDUSTRY

lead

Albert Einstein College of Medicine

OTHER